why choose us

Clinical Trials Search

Showing 3,030 of 131,434 result(s)
The Relationship Between the Density of Cancer-Associated Fibroblasts in the Peritumoral Stroma and Clinicopathological Data in Breast Cancer Patients

Status: COMPLETED

Condition: Breast Carcinoma

Interventions: Routine surgery after neoadjuvant chemotherapy for breast cancer according to current guidelines.

Date: 2024-10-08

Inline Skaters Observational Study.

Status: COMPLETED

Condition: Range of Motion, Articular

Interventions:

Date: 2024-10-08

Dorsal Vetilation and PPCs in Colorectal Cancer Surgery Patients

Status: COMPLETED

Condition: Colorectal Surgery

Interventions:

Date: 2024-10-07

Influence of the Fruit Matrix on Glucose and Insulin Responses After the Intake of Orange Juice in Healthy Human Males

Status: COMPLETED

Condition: Healthy Nutrition

Interventions: 250 mL of commercial 100% orange juice containing 25 g of total sugars (glucose, fructose, saccharose).

Date: 2024-10-07

Cystatin C: a Biomarker of AKI in Aneurysmal Subarachnoid Haemorrhage Patients

Status: COMPLETED

Condition: Acute Kidney Injury

Interventions: a biomarker to assess renal function

Date: 2024-10-07

Educational Program for Patients Undergoing Hemodialysis.

Status: COMPLETED

Condition: Hemodialysis

Interventions: This is the first educational intervention in Morocco to improve the knowledge, self-care, and biological characteristics of patients undergoing hemod

Date: 2024-10-07

Improving the Anabolic Action of Plant-based Foods Using Complementary Proteins

Status: COMPLETED

Condition: Health

Interventions: Participants will perform leg press and leg extension immediately prior to ingestion of rice and beans or isolated mixture.

Date: 2024-10-07

A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men

Status: COMPLETED

Condition: Healthy

Interventions: BI 3810477 formulation A

Date: 2024-10-07

A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men

Status: COMPLETED

Condition: Healthy

Interventions: BI 3810477 formulation A

Date: 2024-10-07

A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria

Status: COMPLETED

Condition: Phenylketonuria (PKU)

Interventions: DRUG: JNT-517 Tablet - JNT-517: 75 mg BID
OTHER: Placebo - Placebo Tablet: BID
DRUG: JNT-517 Tablet - JNT-517: 150 mg BID

Date: 2024-10-07